CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Gift President & CEO gave 3,000 shares (gift)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Material agreement
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 20,000 shares at $0.47 ($9,400)
- 4 Open-market buy VP & Chief Financial Officer bought 60,000 shares at $0.39 ($23,400)
- 4 Open-market buy Director bought 200,000 shares at an average $0.39 ($78,507)
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 8-K Event Delisting notice
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement
Page 40 of 74 · 1,465 filings